EyePoint, Inc. (EYPT)
0.2342
-0.03
(-11.36%)
USD |
NASDAQ |
Nov 20, 16:00
0.2342
0.00 (0.00%)
After-Hours: 20:00
EyePoint Research and Development Expense (TTM) : 296.65M for Sept. 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 296.65M |
| June 30, 2026 | 262.73M |
| March 31, 2026 | 234.61M |
| December 31, 2025 | 221.04M |
| September 30, 2025 | 205.20M |
| June 30, 2025 | 186.99M |
| March 31, 2025 | 161.31M |
| December 31, 2024 | 132.88M |
| September 30, 2024 | 107.45M |
| June 30, 2024 | 95.28M |
| March 31, 2024 | 81.18M |
| December 31, 2023 | 64.66M |
| September 30, 2023 | 62.25M |
| June 30, 2023 | 56.05M |
| March 31, 2023 | 53.32M |
| December 31, 2022 | 49.64M |
| September 30, 2022 | 43.02M |
| June 30, 2022 | 40.35M |
| March 31, 2022 | 32.97M |
| December 31, 2021 | 28.50M |
| September 30, 2021 | 24.79M |
| June 30, 2021 | 20.38M |
| March 31, 2021 | 18.05M |
| December 31, 2020 | 17.42M |
| September 30, 2020 | 16.35M |
| Date | Value |
|---|---|
| June 30, 2020 | 15.74M |
| March 31, 2020 | 16.42M |
| December 31, 2019 | 15.37M |
| September 30, 2019 | 15.42M |
| June 30, 2019 | 18.16M |
| March 31, 2019 | 18.97M |
| December 31, 2018 | 18.50M |
| September 30, 2018 | 18.54M |
| June 30, 2018 | 15.63M |
| March 31, 2018 | 14.03M |
| June 30, 2017 | 14.88M |
| March 31, 2017 | 14.77M |
| December 31, 2016 | 14.56M |
| September 30, 2016 | 14.93M |
| June 30, 2016 | 14.06M |
| March 31, 2016 | 12.93M |
| December 31, 2015 | 13.16M |
| September 30, 2015 | 12.39M |
| June 30, 2015 | 11.86M |
| March 31, 2015 | 11.20M |
| December 31, 2014 | 10.13M |
| September 30, 2014 | 9.853M |
| June 30, 2014 | 9.573M |
| March 31, 2014 | 9.587M |
| December 31, 2013 | 8.905M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ocular Therapeutix, Inc. | 245.94M |
| Corcept Therapeutics, Inc. | 241.72M |
| Hyperion DeFi, Inc. | 0.5365M |
| Context Therapeutics, Inc. | 37.10M |
| Neumora Therapeutics, Inc. | 135.16M |